311 related articles for article (PubMed ID: 27616151)
1. Contralateral adrenal suppression on adrenocortical scintigraphy provides good evidence showing subclinical cortisol overproduction from unilateral adenomas.
Katabami T; Ishii S; Obi R; Asai S; Tanaka Y
Endocr J; 2016 Dec; 63(12):1123-1132. PubMed ID: 27616151
[TBL] [Abstract][Full Text] [Related]
2. Ectopic Cortisol-producing Adrenocortical Adenoma Detected by 131I-6β-iodomethyl-norcholesterol Scintigraphy.
Sato S; Imachi H; Kobayashi T; Fukunaga K; Lyu J; Dong T; Yoshioka Y; Saheki T; Fukata Y; Ban N; Urushihara K; Kadota K; Murao K
Intern Med; 2020 Jul; 59(14):1731-1734. PubMed ID: 32238722
[TBL] [Abstract][Full Text] [Related]
3. High [18F] 2-fluoro-2-deoxy-D-glucose (FDG) uptake of adrenocortical adenoma showing subclinical Cushing's syndrome.
Shimizu A; Oriuchi N; Tsushima Y; Higuchi T; Aoki J; Endo K
Ann Nucl Med; 2003 Jul; 17(5):403-6. PubMed ID: 12971640
[TBL] [Abstract][Full Text] [Related]
4. 131I-6 beta-iodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomas.
Bardet S; Rohmer V; Murat A; Guillemot C; Maréchaud R; Chupin M; Lecomte P; Simon D; Delemer B; Schneebelli S; Beutter D; Jacquin V; Peltier P; Charbonnel B
Clin Endocrinol (Oxf); 1996 May; 44(5):587-96. PubMed ID: 8762736
[TBL] [Abstract][Full Text] [Related]
5. Bilateral adrenocortical adenomas causing ACTH-independent Cushing's syndrome at different periods: a case report and discussion of corticosteroid replacement therapy following bilateral adrenalectomy.
Tung SC; Wang PW; Huang TL; Lee WC; Chen WJ
J Endocrinol Invest; 2004 Apr; 27(4):375-9. PubMed ID: 15233560
[TBL] [Abstract][Full Text] [Related]
6. Proposed diagnostic criteria for subclinical Cushing's syndrome associated with adrenal incidentaloma.
Akehi Y; Kawate H; Murase K; Nagaishi R; Nomiyama T; Nomura M; Takayanagi R; Yanase T
Endocr J; 2013; 60(7):903-12. PubMed ID: 23574729
[TBL] [Abstract][Full Text] [Related]
7. Optimization of left adrenal vein sampling in primary aldosteronism: Coping with asymmetrical cortisol secretion.
Kishino M; Yoshimoto T; Nakadate M; Katada Y; Kanda E; Nakaminato S; Saida Y; Ogawa Y; Tateishi U
Endocr J; 2017 Mar; 64(3):347-355. PubMed ID: 28132968
[TBL] [Abstract][Full Text] [Related]
8. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
Rossi R; Tauchmanova L; Luciano A; Di Martino M; Battista C; Del Viscovo L; Nuzzo V; Lombardi G
J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
[TBL] [Abstract][Full Text] [Related]
9. Pros and cons of dexamethasone suppression test for screening of subclinical Cushing's syndrome in patients with adrenal incidentalomas.
Reimondo G; Allasino B; Bovio S; Saba L; Ardito A; Angeli A; Terzolo M
J Endocrinol Invest; 2011 Jan; 34(1):e1-5. PubMed ID: 20634637
[TBL] [Abstract][Full Text] [Related]
10. Adrenal incidentalomas showing unilateral concordant visualization by adrenocortical scintigraphy: comparison with adenomas in Cushing's syndrome.
Tani A; Nakajo M; Tsuchimochi S; Nakabeppu Y; Umanodan T
Ann Nucl Med; 2000 Jun; 14(3):205-12. PubMed ID: 10921486
[TBL] [Abstract][Full Text] [Related]
11. Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas.
Valli N; Catargi B; Ronci N; Vergnot V; Leccia F; Ferriere JM; Chene G; Grenier N; Laurent F; Tabarin A
Eur J Endocrinol; 2001 Apr; 144(4):401-8. PubMed ID: 11275951
[TBL] [Abstract][Full Text] [Related]
12. Tomographic evaluation of [131I] 6beta-iodomethyl-norcholesterol standardised uptake trend in clinically silent monolateral and bilateral adrenocortical incidentalomas.
Imperiale A; Olianti C; Mannelli M; La Cava G; Pupi A
Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):287-96. PubMed ID: 16172575
[TBL] [Abstract][Full Text] [Related]
13. Plasma and salivary 6beta-hydroxycortisol measurements for assessing adrenocortical activity in patients with adrenocortical adenomas.
Varga I; Jakab C; Szücs N; Patócs A; Tóth M; Kiss R; Gláz E; Rácz K
Horm Metab Res; 2003 Jul; 35(7):421-6. PubMed ID: 12931273
[TBL] [Abstract][Full Text] [Related]
14. Iodocholesterol adrenal tissue uptake and imaging adrenal neoplasms.
Schteingart DE; Seabold JE; Gross MD; Swanson DP
J Clin Endocrinol Metab; 1981 Jun; 52(6):1156-61. PubMed ID: 7229000
[TBL] [Abstract][Full Text] [Related]
15. New diagnostic criteria of adrenal subclinical Cushing's syndrome: opinion from the Japan Endocrine Society.
Yanase T; Oki Y; Katabami T; Otsuki M; Kageyama K; Tanaka T; Kawate H; Tanabe M; Doi M; Akehi Y; Ichijo T
Endocr J; 2018 Apr; 65(4):383-393. PubMed ID: 29576599
[TBL] [Abstract][Full Text] [Related]
16. Adrenal cortical adenoma causing Cushing's syndrome: correct localization by functional scintigraphy despite nonlocalizing morphological imaging studies.
Geatti O; Fig L; Shapiro B
Clin Nucl Med; 1990 Mar; 15(3):168-71. PubMed ID: 2317996
[TBL] [Abstract][Full Text] [Related]
17. Primary adrenocortical nodular dysplasia presented as adrenal adenoma by functional scintigraphy.
García-Mayor RV; Pérez Mendez L; Páramo C; Andrade A; Guitian R; Butron M
Clin Nucl Med; 1993 Mar; 18(3):220-2. PubMed ID: 8462213
[TBL] [Abstract][Full Text] [Related]
18. Does the corticoadrenal adenoma with "pre-Cushing's syndrome" exist?
Charbonnel B; Chatal JF; Ozanne P
J Nucl Med; 1981 Dec; 22(12):1059-61. PubMed ID: 6273512
[TBL] [Abstract][Full Text] [Related]
19. A case of autonomous cortisol secretion in a patient with subclinical Cushing's syndrome, GNAS mutation, and paradoxical cortisol response to dexamethasone.
Sakaguchi C; Ashida K; Kohashi K; Ohe K; Fujii Y; Yano S; Matsuda Y; Sakamoto S; Sakamoto R; Oda Y; Nomura M; Ogawa Y
BMC Endocr Disord; 2019 Jan; 19(1):13. PubMed ID: 30670014
[TBL] [Abstract][Full Text] [Related]
20. Adrenal scintigraphy with 131I-19-iodochlesterol in the diagnosis of Cushing's syndrome associated with adrenal tumor.
Barliev GB
Eur J Nucl Med; 1979 Dec; 4(6):449-51. PubMed ID: 520360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
